Clinical Trial Update: PROPE Severe Asthma Study in Egypt

View source ↗

Summary

Clinical trial update for AstraZeneca's PROPE severe asthma study in Egypt; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: AstraZeneca | Conditions: Severe Asthma | Status: COMPLETED